Signal pathways such as AMP-activated protein kinase (AMPK), mammalian target of rapamycin (mTOR), and sirtuin 1 (SIRT1) and autophagy-related pathways may also bridge T2D and CRC and participate in cancer progression (12). The gene discussed is SIRT1; the disease is cancer.